WO2021260310A1 - Procédé de production de proteines par une souche de champignon trichoderma dans laquelle le gène cel1 a est invalidé - Google Patents
Procédé de production de proteines par une souche de champignon trichoderma dans laquelle le gène cel1 a est invalidé Download PDFInfo
- Publication number
- WO2021260310A1 WO2021260310A1 PCT/FR2021/051117 FR2021051117W WO2021260310A1 WO 2021260310 A1 WO2021260310 A1 WO 2021260310A1 FR 2021051117 W FR2021051117 W FR 2021051117W WO 2021260310 A1 WO2021260310 A1 WO 2021260310A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition
- lactose
- weight
- strain
- sugars
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 171
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 76
- 238000000034 method Methods 0.000 title claims abstract description 65
- 241000223259 Trichoderma Species 0.000 title claims abstract description 45
- 239000000203 mixture Substances 0.000 claims abstract description 195
- 235000000346 sugar Nutrition 0.000 claims abstract description 179
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims abstract description 170
- 239000008101 lactose Substances 0.000 claims abstract description 169
- 239000000758 substrate Substances 0.000 claims abstract description 65
- 238000004519 manufacturing process Methods 0.000 claims abstract description 53
- 241000233866 Fungi Species 0.000 claims abstract description 50
- 230000012010 growth Effects 0.000 claims abstract description 22
- 150000008163 sugars Chemical class 0.000 claims description 111
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 68
- 239000008103 glucose Substances 0.000 claims description 68
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims description 50
- 102000004190 Enzymes Human genes 0.000 claims description 41
- 108090000790 Enzymes Proteins 0.000 claims description 41
- 238000000855 fermentation Methods 0.000 claims description 33
- 230000004151 fermentation Effects 0.000 claims description 33
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 32
- 241000499912 Trichoderma reesei Species 0.000 claims description 29
- 239000002028 Biomass Substances 0.000 claims description 28
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 26
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 26
- 230000001461 cytolytic effect Effects 0.000 claims description 26
- 239000000287 crude extract Substances 0.000 claims description 23
- 150000002972 pentoses Chemical class 0.000 claims description 23
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 16
- 230000002255 enzymatic effect Effects 0.000 claims description 15
- 108010084185 Cellulases Proteins 0.000 claims description 13
- 102000005575 Cellulases Human genes 0.000 claims description 13
- 238000004821 distillation Methods 0.000 claims description 12
- 239000001913 cellulose Substances 0.000 claims description 9
- 229920002678 cellulose Polymers 0.000 claims description 9
- 239000007788 liquid Chemical group 0.000 claims description 8
- 238000006460 hydrolysis reaction Methods 0.000 claims description 6
- 238000002703 mutagenesis Methods 0.000 claims description 6
- 231100000350 mutagenesis Toxicity 0.000 claims description 6
- 238000000926 separation method Methods 0.000 claims description 6
- 230000001476 alcoholic effect Effects 0.000 claims description 5
- 238000002744 homologous recombination Methods 0.000 claims description 5
- 230000006801 homologous recombination Effects 0.000 claims description 5
- 230000007062 hydrolysis Effects 0.000 claims description 5
- 230000007071 enzymatic hydrolysis Effects 0.000 claims description 4
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 claims description 4
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims description 3
- 108010002430 hemicellulase Proteins 0.000 claims description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims 1
- 239000000178 monomer Substances 0.000 claims 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract description 4
- 229910052799 carbon Inorganic materials 0.000 abstract description 4
- 229940088598 enzyme Drugs 0.000 description 34
- 230000008569 process Effects 0.000 description 30
- 239000000243 solution Substances 0.000 description 30
- 239000012071 phase Substances 0.000 description 28
- 239000002551 biofuel Substances 0.000 description 19
- 239000012527 feed solution Substances 0.000 description 18
- 239000010902 straw Substances 0.000 description 15
- 239000000047 product Substances 0.000 description 13
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 11
- 230000006698 induction Effects 0.000 description 11
- 230000001939 inductive effect Effects 0.000 description 11
- 239000001963 growth medium Substances 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 108091034117 Oligonucleotide Proteins 0.000 description 8
- 241000209140 Triticum Species 0.000 description 8
- 235000021307 Triticum Nutrition 0.000 description 8
- 240000008042 Zea mays Species 0.000 description 8
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 8
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 8
- 235000005822 corn Nutrition 0.000 description 8
- 239000003550 marker Substances 0.000 description 8
- 239000013598 vector Substances 0.000 description 8
- 108010059892 Cellulase Proteins 0.000 description 7
- 239000013612 plasmid Substances 0.000 description 7
- 230000014616 translation Effects 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 108020004414 DNA Proteins 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 6
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 6
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 239000002029 lignocellulosic biomass Substances 0.000 description 5
- 230000001954 sterilising effect Effects 0.000 description 5
- 238000004659 sterilization and disinfection Methods 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 230000009466 transformation Effects 0.000 description 5
- 238000011144 upstream manufacturing Methods 0.000 description 5
- 238000010923 batch production Methods 0.000 description 4
- 229940106157 cellulase Drugs 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 238000012239 gene modification Methods 0.000 description 4
- 230000005017 genetic modification Effects 0.000 description 4
- 235000013617 genetically modified food Nutrition 0.000 description 4
- 230000035772 mutation Effects 0.000 description 4
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 3
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 3
- 102000004366 Glucosidases Human genes 0.000 description 3
- 108010056771 Glucosidases Proteins 0.000 description 3
- 102000005744 Glycoside Hydrolases Human genes 0.000 description 3
- 108010031186 Glycoside Hydrolases Proteins 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 235000011114 ammonium hydroxide Nutrition 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 239000000411 inducer Substances 0.000 description 3
- 230000003834 intracellular effect Effects 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Natural products CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 108010008885 Cellulose 1,4-beta-Cellobiosidase Proteins 0.000 description 2
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 2
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 description 2
- 101710112457 Exoglucanase Proteins 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- GOMCKELMLXHYHH-UHFFFAOYSA-L dipotassium;phthalate Chemical compound [K+].[K+].[O-]C(=O)C1=CC=CC=C1C([O-])=O GOMCKELMLXHYHH-UHFFFAOYSA-L 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 210000003527 eukaryotic cell Anatomy 0.000 description 2
- 239000000446 fuel Substances 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- LWGJTAZLEJHCPA-UHFFFAOYSA-N n-(2-chloroethyl)-n-nitrosomorpholine-4-carboxamide Chemical compound ClCCN(N=O)C(=O)N1CCOCC1 LWGJTAZLEJHCPA-UHFFFAOYSA-N 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 235000021309 simple sugar Nutrition 0.000 description 2
- 238000002741 site-directed mutagenesis Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 1
- HFVMEOPYDLEHBR-UHFFFAOYSA-N (2-fluorophenyl)-phenylmethanol Chemical compound C=1C=CC=C(F)C=1C(O)C1=CC=CC=C1 HFVMEOPYDLEHBR-UHFFFAOYSA-N 0.000 description 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 1
- 229940035437 1,3-propanediol Drugs 0.000 description 1
- 101150072734 1a gene Proteins 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- ALRHLSYJTWAHJZ-UHFFFAOYSA-N 3-hydroxypropionic acid Chemical compound OCCC(O)=O ALRHLSYJTWAHJZ-UHFFFAOYSA-N 0.000 description 1
- 108020005029 5' Flanking Region Proteins 0.000 description 1
- 241000609240 Ambelania acida Species 0.000 description 1
- 101100049989 Aspergillus niger xlnB gene Proteins 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 101150096672 CEL1 gene Proteins 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 230000008265 DNA repair mechanism Effects 0.000 description 1
- 101710126559 Endoglucanase EG-II Proteins 0.000 description 1
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000702191 Escherichia virus P1 Species 0.000 description 1
- 101710098247 Exoglucanase 1 Proteins 0.000 description 1
- 101710098246 Exoglucanase 2 Proteins 0.000 description 1
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- GRRNUXAQVGOGFE-UHFFFAOYSA-N Hygromycin-B Natural products OC1C(NC)CC(N)C(O)C1OC1C2OC3(C(C(O)C(O)C(C(N)CO)O3)O)OC2C(O)C(CO)O1 GRRNUXAQVGOGFE-UHFFFAOYSA-N 0.000 description 1
- 240000003433 Miscanthus floridulus Species 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 241000223261 Trichoderma viride Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 101150075580 Xyn1 gene Proteins 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 210000004436 artificial bacterial chromosome Anatomy 0.000 description 1
- 210000004507 artificial chromosome Anatomy 0.000 description 1
- 210000001106 artificial yeast chromosome Anatomy 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 210000003578 bacterial chromosome Anatomy 0.000 description 1
- 239000010905 bagasse Substances 0.000 description 1
- 108010047754 beta-Glucosidase Proteins 0.000 description 1
- 102000006995 beta-Glucosidase Human genes 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- OWBTYPJTUOEWEK-UHFFFAOYSA-N butane-2,3-diol Chemical compound CC(O)C(C)O OWBTYPJTUOEWEK-UHFFFAOYSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 230000001925 catabolic effect Effects 0.000 description 1
- 230000030570 cellular localization Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 102000054767 gene variant Human genes 0.000 description 1
- 230000002573 hemicellulolytic effect Effects 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 150000001261 hydroxy acids Chemical class 0.000 description 1
- GRRNUXAQVGOGFE-NZSRVPFOSA-N hygromycin B Chemical compound O[C@@H]1[C@@H](NC)C[C@@H](N)[C@H](O)[C@H]1O[C@H]1[C@H]2O[C@@]3([C@@H]([C@@H](O)[C@@H](O)[C@@H](C(N)CO)O3)O)O[C@H]2[C@@H](O)[C@@H](CO)O1 GRRNUXAQVGOGFE-NZSRVPFOSA-N 0.000 description 1
- 229940097277 hygromycin b Drugs 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 229960004592 isopropanol Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229910000357 manganese(II) sulfate Inorganic materials 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 238000013386 optimize process Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 1
- 229940072033 potash Drugs 0.000 description 1
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 1
- 235000015320 potassium carbonate Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 229960004063 propylene glycol Drugs 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 238000002731 protein assay Methods 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000029219 regulation of pH Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 150000004666 short chain fatty acids Chemical class 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 229920001221 xylan Polymers 0.000 description 1
- 150000004823 xylans Chemical class 0.000 description 1
- 101150041186 xyn2 gene Proteins 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2434—Glucanases acting on beta-1,4-glucosidic bonds
- C12N9/2437—Cellulases (3.2.1.4; 3.2.1.74; 3.2.1.91; 3.2.1.150)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/145—Fungal isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/38—Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2434—Glucanases acting on beta-1,4-glucosidic bonds
- C12N9/2445—Beta-glucosidase (3.2.1.21)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/14—Preparation of compounds containing saccharide radicals produced by the action of a carbohydrase (EC 3.2.x), e.g. by alpha-amylase, e.g. by cellulase, hemicellulase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
- C12P7/04—Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
- C12P7/06—Ethanol, i.e. non-beverage
- C12P7/065—Ethanol, i.e. non-beverage with microorganisms other than yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
- C12P7/04—Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
- C12P7/06—Ethanol, i.e. non-beverage
- C12P7/08—Ethanol, i.e. non-beverage produced as by-product or from waste or cellulosic material substrate
- C12P7/10—Ethanol, i.e. non-beverage produced as by-product or from waste or cellulosic material substrate substrate containing cellulosic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01004—Cellulase (3.2.1.4), i.e. endo-1,4-beta-glucanase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01021—Beta-glucosidase (3.2.1.21)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P2201/00—Pretreatment of cellulosic or lignocellulosic material for subsequent enzymatic treatment or hydrolysis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P2203/00—Fermentation products obtained from optionally pretreated or hydrolyzed cellulosic or lignocellulosic material as the carbon source
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
- C12R2001/885—Trichoderma
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E50/00—Technologies for the production of fuel of non-fossil origin
- Y02E50/10—Biofuels, e.g. bio-diesel
Definitions
- the present invention relates to a process for the production of proteins using (i) a strain of fungus belonging to the genus Trichoderma in which the ceUa gene is invalidated, and (ii) an optimized inducer composition.
- the strains of fungus belonging to the Trichoderma genus, in particular Trichoderma reesei, are today mainly used for the production of enzymes.
- These enzymes for example cellulases, are in fact used to hydrolyze cellulosic or lignocellulosic biomass into simple sugars.
- the enzymes produced by filamentous fungi are therefore useful in the production sectors of second-generation biofuels or even biobased products derived from sugars originating from (ligno) cellulosic biomass.
- patent EP 448 430 B1 describes an optimized industrial production of cellulases by Trichoderma reesei. This production is carried out in a fed-batch protocol (feed without drawing off) using a feed solution containing lactose as inducing sugar in the production of proteins. This fermentation process comprises two stages: a first stage of growth of the fungus in the presence of an excess of carbon source and a second stage of production of enzymes thanks to the addition of an inducer in the medium with an optimized flow rate ( fed-batch mode). These steps are carried out in a liquid medium in bioreactors with stirring and in the presence of oxygen because the fungus is strictly aerobic. Another example of an optimized process for the production of cellulases is described in patent EP 2744899 B1.
- Jourdier et al. have shown that it is possible to replace part of the lactose with other less expensive sugars such as glucose and / or purified xylose (see Jourdier et al. Biotechnology for Biofuels 2013, 6:79).
- the authors notably analyzed the impact of glucose and / or xylose on the secretion of enzymes by a hyperproductive strain of Trichoderma reesei (strain CL847). This study thus makes it possible to conclude that in the industrial strain CL847 which comes from the hyperproductive model strain RutC30, the induction capacity is positively correlated with the lactose content present in the feed solution: the higher the lactose content, the better the induction.
- International application PCT / FR2011 / 000350 also describes a process for the production of cellulolytic and / or hemicellulolytic enzymes using, during the production phase, a composition comprising from 40 to 65% by weight of glucose, from 21 to 25 wt% lactose and 10-39 wt% xylose in combination with a Trichoderma reesei fungus disabled for catabolic repression by glucose.
- CEL1a and CEL1b are Essential for Cellulase Induction on Lactose in Trichoderma reesei, Eukaryotic Cell 13 (8), pp. 1001-1013 (2014)) described the invalidation of the cella gene in the parent strain Trichoderma reesei TU-6 (ATCC MYA-256).
- the team of Xu et al. concludes in particular that the CEL1a protein is an intracellular ⁇ -glucosidase which is essential in induction by lactose.
- the present invention is based on the unexpected results of the inventors who have demonstrated that it was possible to induce the production of proteins using an inducing composition containing less, if at all, lactose, namely a composition containing 0% by weight of lactose relative to the total content of sugars in said composition, or lactose at a content greater than 0% by weight and at most 30% by weight of the content total sugars in said composition, and being in particular between 5% by weight and 30% by weight of the total content of sugars in said composition, using a strain of the fungus Trichoderma, in particular Trichoderma reesei, in which the genome has been modified in order to invalidate the cella gene.
- lactose the inducing composition comprising at least one other sugar (also called in the text “second sugar”); lactose is no longer used here at all;
- the inventors have in particular shown that the invalidation of the cella gene in a strain of Trichoderma reesei made it possible to divide by 10 the quantity of lactose used in the production phase, or even to eliminate it completely, while maintaining an equivalent specific productivity by compared to a reference strain.
- the inventors have in particular shown that the strain invalidated for cella, although it does not produce proteins when it is supplied with pure glucose or with pure lactose, correctly produces proteins when it is supplied with glucose / lactose mixtures, with an advantageous range for lactose contents in the feed solution of between 5% and 30% by weight of the accumulation of sugars, in particular for contents of between 10% and 20% by weight.
- feed solutions having lactose contents comprising between 10 and 15% by weight of the accumulation of sugars give an equivalent induction as pure lactose in the parent strain (in which the gene cella has not been invalidated), with specific protein production rates of the order of 20 ⁇ 2 mg protein / g biomass / h.
- the present invention is based on the use, during the step of producing proteins in the fed-batch phase, of a composition comprising a second sugar, and optionally at least lactose, the lactose content in said.
- composition being equal to 0% by weight of the total content of sugars in said composition, or being greater than 0% by weight and at most 30% by weight of the total content of sugars in said composition.
- the present invention thus relates to a process for the production of proteins by a strain of fungus belonging to the genus Trichoderma in which the cella gene is invalidated, comprising at least two steps: - a first batch phase growth step in the presence of at least one carbonaceous growth substrate, and
- a second step of producing proteins in the fed-batch phase in the presence of a composition comprising at least lactose and a second sugar, the lactose content in said composition representing approximately between 0 and 30% by weight of the total content of sugars in said composition.
- the present invention thus relates to a process for the production of proteins by a strain of fungus belonging to the genus Trichoderma in which the ceUa gene is invalidated, comprising at least two steps:
- a second step of producing proteins in the fed-batch phase in the presence of a composition comprising at least lactose and a second sugar, the lactose content in said composition representing approximately between 5 and 30% by weight of the total content of sugars in said composition.
- the present invention also relates to the use of a composition comprising at least lactose and a second sugar, the lactose content in said composition representing approximately between 0 and 30%, in particular between 5 and 30%, by weight of the total content of sugars in said composition for the production of proteins of interest by a strain of fungus belonging to the genus Trichoderma in which the ceUa gene is invalidated.
- the present invention also relates to a process for the production of sugars from cellulosic or lignocellulosic substrates, comprising a step of producing cellulolytic enzymes by a strain of fungus belonging to the genus Trichoderma in which the ceUa gene is invalidated, in the presence of a composition comprising at least lactose and a second sugar, the lactose content in said composition representing approximately between 0 and 30%, in particular between 5 and 30%, by weight of the total content of sugars in said composition.
- the invention therefore relates to the use of a strain of fungus belonging to the genus Trichoderma in which the ceUa gene is invalidated, for the hydrolysis of cellulose or lignocellulose to sugar.
- the present invention also relates to a process for the production of biobased products from cellulosic or lignocellulosic substrates, comprising a stage of production of cellulolytic enzymes by a strain of fungus belonging to the genus Trichoderma in which the ceUa gene is invalidated, in presence of a composition comprising at least lactose and a second sugar, the lactose content in said composition representing approximately between 0 and 30%, in particular 5 and 30%, by weight of the total content of sugars in said composition.
- the invention therefore relates to the use of a strain of fungus belonging to the Trichoderma genus in which the cel1a gene is invalidated, for the production of bio-based products from cellulosic or lignocellulosic substrates.
- the present invention also relates to a method of producing a biofuel / alcohol from cellulosic or lignocellulosic substrates, comprising a step of producing cellulolytic enzymes by a strain of fungus belonging to the genus Trichoderma in which the gene cella is invalidated, in the presence of a composition comprising at least lactose and a second sugar, the lactose content in said composition representing approximately between 0 and 30%, in particular between 5 and 30%, by weight of the total content of sugars in said composition.
- the invention therefore relates to the use of a strain of fungus belonging to the genus Trichoderma in which the cella gene is invalidated, for the production of biofuel / alcohol from cellulosic or lignocellulosic substrates.
- the present invention finally relates to a strain of fungus belonging to the species Trichoderma reesei, said strain being derived from the strain as deposited under the reference ATCC 56765 and said strain comprising an invalidation of the cella gene.
- the present invention also relates more generally to a strain derived from the Rut-C30 strain, and said strain comprising an invalidation of the cella gene.
- the invention thus relates to a process for the production of proteins by a strain of fungus belonging to the genus Trichoderma in which the cella gene is invalidated, comprising at least two steps:
- a second step of producing proteins in the fed-batch phase in the presence of a composition comprising at least lactose and a second sugar, the lactose content in said composition representing approximately between 0 and 30% or between 5 and 30%, by weight of the total content of sugars in said composition.
- the invention relates to a method of producing proteins by a strain of fungus belonging to the genus Trichoderma in which the cella gene is invalidated, comprising at least two steps:
- the expression "approximately between 0 and 30% by weight of the total content of sugars in said composition” means a lactose content greater than or equal to 0% and strictly less than 5% and / or a content between 5 and 30% by weight of the total content of sugars in said composition.
- This also means a lactose content greater than or equal to 0.01% (preferably 0.1% or 1%) and strictly less than 5% and / or a content between 5 and 30% by weight of the total content of sugars in said composition.
- composition used in the fed-batch step according to the invention can thus:
- lactose but at a content of between 0.01% and 30% by weight of the total content of sugars in said composition.
- composition used in the fed-batch step according to the invention can thus:
- lactose but at a content of between 0.1% and 30% by weight of the total content of sugars in said composition.
- composition used in the fed-batch step according to the invention can thus:
- composition used in the fed-batch step according to the invention can thus comprise lactose and another (second) sugar or else comprise at least one sugar other than lactose, preferably at least two sugars.
- the invention relates to a method of producing proteins by a strain of fungus belonging to the genus Trichoderma in which the cella gene is invalidated, comprising at least two steps:
- the lactose content in said composition representing between 0.01 and 30% by weight of the total content of sugars in said composition.
- the composition used in the fed-batch step according to the invention comprises:
- a lactose content greater than or equal to 5.00% and less than or equal to 30.00% by weight of the total content of sugars in said composition.
- the expression “strictly greater than 0.00%” means a value of at least 0.01%, in particular at least 0.1%, and preferably at least 1%, and the expression “strictly less than 5.00 % ”Refers to values up to 4.99%.
- the lactose content in the composition used during the fed-batch step is between more than 0% and 5% by weight of the total content of sugars in said composition, or between more from 5% and less than 10% by weight of the total sugar content in said composition, or from 10% by weight to at most 20% by weight of the total sugar content in said composition.
- the ceUa gene corresponds to the gene represented by SEQ ID NO: 1 or a gene having at least 80% identity with SEQ ID NO: 1.
- the cella gene is also named TRIREDRAFT_120749 in the genome reference Trichoderma reesei (b3 ⁇ 4tps: //www.uniproi.ora/uniprot/GQRD31).
- This gene encodes a CEL1a protein belonging to family 1 of glycoside hydrolases. More specifically, CEL1a is an intracellular b-glucosidase, also called bgl2 or bglll, (M. Saloheimo, J. Kuja-Panula, E. Ylôsmàki, et al. (2002) Enzymatic Properties and Intracellular Localization of the Novel Trichoderma reesei b-
- Glucosidase BGLII (Cel1A). Applied and Environmental Microbiology, 68 (9) 4546-4553).
- the CEL1a protein is represented by SEQ ID NO: 2.
- the ceUa gene is the reference gene in Trichoderrma reesei.
- a gene having at least 80% identity thus represents a variant of this gene or else an orthologous gene in another species of Trichoderma.
- the expression “at least 80% identity with SEQ ID NO: 1” means all the values between 80% and 100%, in particular the values of 80%, 81%, 82%, 83% , 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% and 100 %, preferably at least 90%, at least 95%, still more particularly at least 98%, at least 99%.
- the percentage identity of a given sequence relative to SEQ ID NO: 1 means the percentage identity over the total length of the sequences. The percentage thus corresponds to the number of nucleotides (residues if any) identical between this given sequence and SEQ ID NO: 1 divided by the number of nucleotides (residues if any) in the longer of the two sequences.
- the CEL1 A protein is encoded by an orthologous gene or a variant of the cel1 gene, said protein may be represented by a protein having at least 80% identity with SEQ ID NO: 2, in particular at least 90%, at least 95%, preferably at least 98% or at least 99%.
- the fungus belongs to the species Trichoderma reesei.
- the cella gene is preferably represented by SEQ ID NO: 1 or a sequence having at least 98% identity with SEQ ID NO: 1.
- the cella gene is represented by SEQ ID NO: 1.
- the parent strain of Trichoderma reesei can in particular be the strain QM6a (deposited under the number ATCC 13631), or a strain resulting from the natural isolate QM6a (in particular obtained by random or directed mutagenesis), such as the strain Rut-C30 (deposited under the number ATCC 56765), the strain deposited under the number CNCM 1-5221 (deposited on August 3, 2017 with the CNCM, National Collection of Cultures of Microorganisms of the Pasteur Institute, located 25 rue du Do Budapest Roux, F-75724 Paris cedex 15), the strain NG14 (deposited under the number ATCC 56767) or the strain QM9414 (deposited under the number ATCC 26921).
- the strain QM6a deposited under the number ATCC 13631
- a strain resulting from the natural isolate QM6a in particular obtained by random or directed mutagenesis
- the strain Rut-C30 deposited under the number ATCC 56765
- the strain deposited under the number CNCM 1-5221 deposited on August 3,
- proteins are all the proteins which can be produced by a fungus, naturally or else by genetic modification (for example after transformation using an appropriate vector).
- the proteins of interest according to the invention are enzymes, in particular cellulolytic enzymes such as cellulases or hemicellulases.
- the enzymes are cellulases.
- the term "cellulases” is understood more particularly to mean enzymes belonging to the family of glycoside hydrolases, for example chosen from endoglucanases, exoglucanases and glucosidases.
- glycoside hydrolases are in particular grouped together under the nomenclature “EC 3.2.1. ".
- cellulase more particularly refers to an enzyme suitable for the hydrolysis of cellulose and allowing microorganisms (such as Trichoderma reesei) which produce them to use cellulose as a source of carbon, by hydrolyzing this polymer into simple sugars. (glucose).
- microorganisms such as Trichoderma reesei
- the production of cellulases by a strain according to the invention, in particular Trichoderma reesei can be determined by any techniques customary for a person skilled in the art, or alternatively by the techniques described in patents EP 448 430 B1 or EP 2744899 B1.
- the lactose content representing approximately between 0 and 30% by weight of the total content of sugars means that during the fed-batch step, between 70 and 100% by weight of the sugars added by said composition are one or more sugars other than lactose.
- the expression “the lactose content representing approximately between 5 and 30% by weight of the total content of sugars” means that during the fed-batch stage, between 70 and 95% by weight of the sugars provided by said composition are a sugar or sugars other than lactose.
- the total content of sugars thus corresponds to 100% by weight of the content of sugars in the composition.
- the method according to the invention is carried out in a stirred and aerated bioreactor. More particularly, the stirring speed is controlled, in particular in order to maintain a dissolved oxygen concentration greater than 40% of the saturation concentration.
- the stirring speed is generally controlled between 400 and 1200 rpm.
- the temperature is controlled during the first and the second step, in particular between 20 and 35 ° C. More particularly, the temperature is controlled at 27 ° C during the first step and at 25 ° C during the second step.
- the pH is controlled. More particularly, the pH is controlled at 4.0, in particular by automatic addition of a 5N ammonia solution.
- the first phase takes place until the carbonaceous growth substrate is used up.
- This first stage generally lasts between about 18 and 48 hours, in particular for 24 to 36 hours.
- the second phase takes place for approximately 70 to 240 hours, in particular 70 hours.
- the first phase lasts between 18 and 48 hours, in particular for 24 to 36 hours, and the second phase takes place for approximately 70 to 240 hours, in particular 70 hours.
- the method according to the invention allows to obtain a productivity of between 14 and 25 mg P rotéines / gbiomasse / h, in particular between 14 and 23 mgpro Téi nes / g bi omasse / h. According to one embodiment, the method according to the invention allows to obtain a productivity of between 15 and 20 mg pro teins / gbiomasse / h, in particular between 16 and 19 mg P rotéines / gbiomasse / h.
- the induction ability of a solution of sugars on a stump is judged by measuring the specific rate of protein production (also called “specific productivity"), expressed in mg otéines r / gbiomasse / h, in a culture with supply of the solution of sugars at optimized flow rate.
- specific productivity also called "specific productivity”
- the proteins produced by Trichoderma reesei are mainly enzymes, including cellulases.
- a correlation between total secreted proteins and cellulases can be made because in Trichoderma reesei, the main exoglucanases (CBHI, CBHII) and endoglucanases (EGI, EGII) can represent up to 90% of the total amount of secreted proteins (see for example Markov, AV, Gusakov, AV, Kondratyeva, EG, Okunev, ON, Bekkarevich, AO, and Sinitsyn, AP (2005). New Effective Method for Analysis of the Component Composition of Enzyme Complexes from Trichoderma reesei. Biochemistry (Moscow) 70, 657-663). Thus, the productivity of enzymes or of cellulases is therefore equivalent to the productivity of proteins.
- a strain of fungus belonging to the genus Trichoderma in which the cella gene is invalidated means that the genome of the strains used in the present invention has been modified so that the cella gene is no longer expressed (or the gene variant or the orthologous gene if applicable).
- the CEL1a protein is not produced or else a non-functional CEL1a is produced (ie the protein is no longer biologically active).
- the genome of the strain according to the invention is modified (or has been modified) so that the CEL1a protein is not synthesized or is synthesized in a non-functional form.
- the CEL1a protein is not produced / synthesized.
- the invalidation of a gene is well known to those skilled in the art.
- the cella gene has been invalidated in the strain by mutagenesis or by homologous recombination, in particular using an invalidation cassette such as represented by SEQ ID NO: 3.
- the present invention thus relates to the use of a variant strain of the Trichoderma fungus, in which the cella gene has been invalidated.
- the term "variant strain” means a strain genetically modified from a parent strain.
- the term “parent strain” thus means a strain from which the variant strain is derived or derived, and in which the cella gene has not been invalidated.
- the strain according to the invention thus corresponds to a variant strain derived from a parent strain, said variant strain comprising at least one genetic modification corresponding to the invalidation of the cella gene relative to the parent strain.
- the “carbonaceous growth substrate” is preferably chosen from lactose, glucose, xylose, liquid residues obtained after ethanolic fermentation (optionally obtained after ethanolic fermentation then distillation) of the monomeric sugars of the enzymatic hydrolysates of biomass.
- cellulosic a crude extract of water-soluble pentoses originating from the pretreatment of a cellulosic biomass, an enzymatic hydrolyzate of lignocellulose (that is to say before fermentation), and / or a hydrolyzate of starchy biomass.
- the substrate is chosen from glucose, xylose, liquid residues obtained after ethanolic fermentation (optionally obtained after ethanolic fermentation then distillation of the monomeric sugars of the enzymatic hydrolysates of cellulosic biomass, a crude extract of water-soluble pentoses originating from the pretreatment of a cellulosic biomass, an enzymatic hydrolyzate of lignocellulose (that is to say before fermentation), and / or a hydrolyzate of starchy biomass
- the substrate is glucose.
- the concentration of carbonaceous growth substrate is in particular between 10 and 80 g / L, in particular between 15 and 40 g / L.
- composition used in the second protein production step of the process according to the invention can also be called “feed solution” or "sugar feed solution”.
- this composition comprises at least two sugars: lactose and another sugar.
- this composition comprises at least three different sugars: lactose and two other sugars.
- said composition used in the second protein production step of the process comprises at least one sugar except lactose, preferably at least two sugars except lactose.
- Lactose is an inducing substrate, that is to say it allows the expression of proteins, in particular cellulases, in the culture medium.
- said second sugar is not an inducing sugar but is nevertheless a carbonaceous substrate.
- the sugar concentration of the composition used during the fed-batch step is in particular between 200 and 600 g / L, in particular between 200 and 500 g / L or between 250 g / L and 500 g / L.
- the second sugar (or the "at least one sugar except lactose") is provided via a solution of glucose and / or xylose (preferably purified), a starchy biomass hydrolyzate, a enzymatic hydrolyzate of lignocellulosic biomass, a crude extract of water-soluble pentoses originating from the pretreatment of a cellulosic biomass and / or the liquid residues obtained after ethanolic fermentation (optionally obtained after ethanolic fermentation then distillation) of the monomeric sugars of the enzymatic hydrolysates of cellulosic biomass.
- the present invention thus makes it possible to use industrial sugar solutions, on condition that they are optionally supplemented with lactose, to induce the production of proteins.
- the composition comprising at least lactose and a second sugar can thus also be called an inducing composition.
- the composition / feed solution used in the fed-batch step thus corresponds to a solution of glucose and / or xylose (preferably purified), a hydrolyzate of starchy biomass, an enzymatic hydrolyzate.
- lignocellulosic biomass a crude extract of water-soluble pentoses originating from the pretreatment of a cellulosic biomass and / or the liquid residues obtained after ethanolic fermentation (optionally obtained after ethanolic fermentation then distillation) of the monomeric sugars of the enzymatic hydrolysates of cellulosic biomass, in which lactose is added so that the lactose content in said composition represents approximately between 0 and 30%, in particular 5 and 30%, by weight of the total content of sugars.
- said second sugar or said “at least one sugar other than lactose” is chosen from glucose, xylose, liquid residues obtained after ethanolic fermentation (optionally obtained after ethanolic fermentation then distillation) monomeric sugars from enzymatic hydrolysates of cellulosic biomass, a crude extract of water-soluble pentoses from the pretreatment of cellulosic biomass, an enzymatic hydrolyzate of lignocellulose, and / or a hydrolyzate of starchy biomass, preferably glucose, xylose and / or a crude extract of hydrolubic pentoses.
- a starchy biomass hydrolyzate mainly contains glucose.
- an enzymatic hydrolyzate of lignocellulosic biomass mainly contains glucose and xylose.
- a crude extract of water-soluble pentoses from the pretreatment of cellulosic biomass mainly contains xylose.
- the cellulosic biomass used can for example be wheat straw, corn straw, corn cobs, sugar cane bagasse, miscanthus, poplar, birch, and any other product or by-product. agricultural and forestry industries.
- the crude extract of water-soluble pentoses is prepared by pretreatment of wheat straw or corn straw.
- a steam explosion pretreatment process is described for example in application WO 2019/120994 A1.
- a pretreatment and extraction process making it possible to prepare a crude extract of water-soluble pentoses is described for example in patent application EP 3587583 A1.
- the liquid residues obtained after ethanolic fermentation (optionally obtained after ethanolic fermentation then distillation) of the monomeric sugars of the enzymatic hydrolysates of cellulosic biomass mainly contain non-fermentable sugars (arabinose, mannose, galactose) and residues of fermentable sugars ( glucose and xylose).
- the second sugar is chosen from glucose and / or xylose, preferably glucose.
- said composition comprises only lactose and glucose as sugar, OR only lactose and xylose OR only lactose, glucose and xylose.
- said composition used during the fed-batch production step comprises glucose, lactose and a crude extract of water-soluble pentoses (in particular originating from the pretreatment of a cellulosic biomass such as corn straw or wheat straw).
- said composition used during the fed-batch production step comprises glucose, a crude extract of water-soluble pentoses (in particular originating from the pretreatment of a cellulosic biomass such as corn straw or wheat straw. ) and is lactose-free.
- the percentages of lactose, glucose and / or xylose, and / or the crude extract of water-soluble pentoses in the composition are calculated relative to the total content by weight of sugars in said composition .
- the total sugar content is that used during the fed-batch mode.
- the content of each sugar in the composition / solution is for example measured by high performance liquid chromatography (HPLC), optionally after concentration by evaporation.
- HPLC high performance liquid chromatography
- purified lactose or glucose powder is dissolved, or a concentrated solution of glucose is mixed.
- the new contents of each sugar are then remeasured by HPLC in the final mixture.
- the composition during the fed-batch step is added / supplied continuously, in a limiting flow.
- concentration of sugars in the culture medium is controlled so as to maintain a residual concentration of sugars in the culture medium close to zero.
- the sugar concentration in the culture medium is less than 1 g / L during this phase, in particular less than 0.5 g / L, more particularly less than 0.1 g / L. This thus promotes the induction and production of proteins.
- the calculation of the optimized flow rate of said composition must be done not in relation to the lactose concentration of the solution but by cumulating the concentration of all the sugars present in the solution.
- the mass flow rate in gsucres / h
- the volume flow rate of the feed solution in L / h
- said composition in the production step is supplied at a flow rate of between 0.8 and 8 rnLsoiution / Lmiiieu / h, preferably between 1 and 3 rnLsoiution / Lmiiieu / h.
- mLsoiution here represents the volume of said composition (feed solution for the fed-batch mode)
- Lmmeu here represents the volume of the bioreactor / fermenter.
- the expression “approximately between 0 and 30% by weight of the total content of sugars in said composition” or “approximately between 5 and 30% by weight of the total content of sugars in said composition” represents all values between 0 and 30, that is, 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16 , 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29 and 30. More specifically, the term “approximately” means that values very slightly less than 5 (for example included between 4.5 and 5) are in the range 5-30%. This also means that values very slightly above 30 (eg between 30 and 30.5) are in the range 5-30%.
- said composition comprises, relative to the total content of sugars in said composition:
- said composition comprises, relative to the total content of sugars in said composition:
- the lactose content in said composition represents approximately between 10 and 20% by weight, in particular between 10 and 20% by weight, of the total content of the sugars in said composition.
- said composition comprises:
- lactose approximately between 10-20% by weight of lactose, and more particularly
- the lactose content in said composition represents approximately between 10 and 15% by weight, in particular between 10 and 15% by weight, of the total content of the sugars in said composition.
- said composition comprises:
- lactose approximately between 10-15% by weight of lactose, and more particularly
- said composition comprises:
- the sugar content in said composition consists of 100% of crude extract of water-soluble pentoses and of glucose.
- the substrates are sterilized.
- the carbonaceous growth substrate is introduced into the bioreactor before sterilization.
- the carbonaceous growth substrate is sterilized separately and then introduced into the bioreactor after sterilization.
- the composition of sugars used during the fed-batch step is sterilized separately and then introduced into the bioreactor after sterilization.
- the invention relates to the use of a composition comprising at least lactose and a second sugar, the lactose content in said composition representing approximately between 0% and 30% or between 5% and 30%. %, by weight of the total content of sugars in said composition, for the production of proteins of interest by a strain of fungus belonging to the genus Trichoderma in which the cella gene is invalidated.
- the invention in a second aspect, relates to the use of a composition comprising at least lactose and a second sugar, the lactose content in said composition representing 0% by weight of lactose of the total content of sugars in said. composition, or lactose in a content greater than 0% by weight and at most 30% by weight of the total content of sugars in said composition, and being in particular between 5% by weight and 30% by weight of the total content of sugars in said composition said composition, for the production of proteins of interest by a strain of fungus belonging to the genus Trichoderma in which the cella gene is invalidated.
- the invention in a third aspect, relates to a process for the production of sugars from cellulosic or lignocellulosic substrates, comprising a step of producing cellulolytic enzymes by a strain of fungus belonging to the genus Trichoderma in which the cella gene is invalidated, in the presence of a composition comprising at least lactose and a second sugar, the lactose content in said composition representing approximately between 0% and 30% or between 5% and 30%, by weight of the total content of sugars in said composition.
- the invention in a third aspect, relates to a process for the production of sugars from cellulosic or lignocellulosic substrates, comprising a step of producing cellulolytic enzymes by a strain of fungus belonging to the genus Trichoderma in which the cella gene is invalidated, in the presence of a composition comprising at least lactose and a second sugar, the lactose content in said composition representing 0% by weight of lactose of the total content of sugars in said composition, or lactose in content greater than 0% by weight and at most 30% by weight of the total content of sugars in said composition, and being in particular between 5% by weight and 30% by weight of the total content of sugars in said composition.
- the invention relates to the use of a strain of fungus belonging to the genus Trichoderma in which the cella gene is invalidated, for the hydrolysis of cellulose or lignocellulose to sugar.
- the invention in a fourth aspect, relates to a process for the production of biobased products from cellulosic or lignocellulosic substrates, comprising a step of producing cellulolytic enzymes by a strain of fungus belonging to the genus Trichoderma in which the cella gene is invalidated, in the presence of a composition comprising at least lactose and a second sugar, the lactose content in said composition representing approximately between 0% and 30% or between 5% and 30%, by weight of the total content of sugars in said composition.
- the invention relates to a process for the production of biobased products from cellulosic or lignocellulosic substrates, comprising a step of producing cellulolytic enzymes by a strain of fungus belonging to the genus Trichoderma in which the cella gene is invalidated, in the presence of a composition comprising at least lactose and a second sugar, the lactose content in said composition being 0% by weight of lactose of the total content of sugars in said composition, or lactose with a content greater than 0% by weight and at most 30% by weight of the total content of sugars in said composition, and being in particular between 5% by weight and 30% by weight of the total content of sugars in said composition.
- the invention relates to the use of a strain of fungus belonging to the genus Trichoderma in which the cella gene is invalidated, for the production of bio-based products from cellulosic or lignocellulosic substrates.
- biobased products is understood more particularly of molecules of interest to the chemical industry, such as for example organic acids such as acetic, propionic, acrylic, butyric, succinic or malic acid. , fumaric, citric, itaconic, or hydroxy acids such as glycolic, hydroxypropionic, or lactic acid, as well as other types of bio-based products such as solvents and alcohols, for example ethanol, acetone, isopropanol, butanol.
- organic acids such as acetic, propionic, acrylic, butyric, succinic or malic acid.
- fumaric, citric, itaconic or hydroxy acids
- glycolic, hydroxypropionic, or lactic acid as well as other types of bio-based products
- solvents and alcohols for example ethanol, acetone, isopropanol, butanol.
- the invention relates to a process for producing a biofuel / alcohol, in particular ethanol, from cellulosic or substrate substrates.
- lignocellulosics comprising a step of producing cellulolytic enzymes by a strain of fungus belonging to the genus Trichoderma in which the ceUa gene is invalidated, in the presence of a composition comprising at least lactose and a second sugar, the lactose content in said composition representing approximately between 0% and 30% or between 5% and 30%, by weight of the total content of sugars in said composition.
- the invention relates to a process for producing a biofuel / alcohol, in particular ethanol, from cellulosic or lignocellulosic substrates, comprising a step of producing cellulolytic enzymes by a strain of fungus belonging to the Trichoderma genus in which the ceUa gene is invalidated, in the presence of a composition comprising at least lactose and a second sugar, the lactose content in said composition comprising 0% by weight of lactose of the total content of sugars in said composition, or lactose in a content greater than 0% by weight and at most 30% by weight of the total content of sugars in said composition, and being in particular between 5% by weight and 30% by weight of the total content of sugars in said composition.
- the invention relates to the use of a strain of fungus belonging to the genus Trichoderma in which the ceUa gene is invalidated, for the production of biofuel / alcohol from cellulosic or lignocellulosic substrates .
- biofuel is understood more particularly to mean a second generation biofuel, that is to say derived from non-food resources.
- biofuel can also be defined as being any product resulting from the transformation of biomass and which can be used for energy purposes.
- biogas products which can be incorporated (optionally after subsequent processing) into a fuel or be a fuel in its own right, such as alcohols ( ethanol, butanol and / or isopropanol depending on the type of fermentation organism used), solvents (acetone), acids (butyric), lipids and their derivatives (short or long chain fatty acids, acid esters fatty), as well as hydrogen.
- the biofuel according to the invention is an alcohol, for example ethanol, butanol, isopropanol, 1,2-propane diol, 1,3-propane diol, 1, 4-butane diol. , and / or 2,3-butanediol. More preferably, the biofuel according to the invention is ethanol. In another embodiment, the biofuel is biogas.
- said process for producing a biofuel or alcohol from cellulosic or lignocellulosic substrates comprises the following steps:
- a stage of production of cellulolytic enzymes by a strain of fungus belonging to the genus Trichoderma in which the ceUa gene is invalidated in the presence of a composition comprising at least lactose and a second sugar, the lactose content in said composition representing approximately between 0% and 30% or between 5% and 30%, by weight of the total content of sugars in said composition,
- step iii) a step of enzymatic hydrolysis of the pretreated substrate, in the presence of the cellulolytic enzymes obtained in step ii) and of an appropriate substrate, in order to obtain a hydrolyzate
- said process for producing a biofuel or alcohol from cellulosic or lignocellulosic substrates comprises the following steps:
- step iii) a step of enzymatic hydrolysis of the pretreated substrate, in the presence of the cellulolytic enzymes obtained in step ii) and of an appropriate substrate, in order to obtain a hydrolyzate
- said process for producing a biofuel or alcohol from cellulosic or lignocellulosic substrates comprises the following steps:
- step iii) a step of enzymatic hydrolysis of the pretreated substrate, in the presence of the cellulolytic enzymes obtained in step ii) and of an appropriate substrate, in order to obtain a hydrolyzate
- the step of pretreatment of a cellulosic or lignocellulosic substrate is a step of suspending said cellulosic or lignocellulosic substrate in the aqueous phase.
- the hydrolyzate obtained in step iii) is a hydrolyzate containing glucose.
- the alcoholic fermentation step of the hydrolyzate obtained is a fermentation step, in the presence of a fermenting organism, of the glucose obtained from the hydrolyzate so as to produce a fermentation must .
- a fermentation organism is, for example, a yeast.
- the separation step is a separation of the biofuel or alcohol and the fermentation must, in particular by distillation.
- the pretreated cellulosic or lignocellulosic substrate to be hydrolyzed is suspended in the aqueous phase at a rate of 6 to 40% of dry matter, preferably 20 to 30%.
- the pH is adjusted between 4 and 5.5, preferably between 4.8 and 5.2 and the temperature between 40 ° C and 60 ° C, preferably between 45 ° C and 50 ° C.
- the hydrolysis reaction is started by adding enzymes acting on the pretreated substrate.
- the usual amount of enzymes used is 10 to 30 mg of protein per gram of pretreated substrate or less.
- the reaction generally lasts 15 to 48 hours.
- the reaction is monitored by assaying the sugars released, in particular glucose.
- the sugar solution is separated from the non-hydrolyzed solid fraction, essentially consisting of lignin, by filtration or centrifugation and then treated in a fermentation unit.
- the enzymes and the fermenting organism are added simultaneously and then incubated at a temperature between 30 ° C and 35 °. C to produce a fermentation must.
- the cellulose present in the pretreated substrate is converted into glucose, and at the same time, in the same reactor, the fermenting organism (for example a yeast) converts the glucose into the final product according to an SSF process ( Simultaneous Saccharification and Fermentation) known to those skilled in the art.
- SSF process Simultaneous Saccharification and Fermentation
- the good progress of the operation may require the addition of a greater or lesser quantity of exogenous cellulolytic mixture.
- the invention in a sixth aspect, relates to a strain of fungus belonging to the species Trichoderma reesei, said strain being derived from the strain as deposited under the reference ATCC 56765 (Rut-C30) and said strain comprising an invalidation of the cella gene.
- the invention thus also relates to a RutC30 strain, the genome of which has been modified in order to invalidate the ceUa gene.
- the invention also relates to a strain derived from the RutC30 strain, the genome of which has been modified in order to invalidate the ceUa gene.
- This variant strain of RutC30 is therefore a strain in which the CEL1a protein is not produced, or else a non-functional CEL1a protein is produced.
- such a strain is obtained by a process for the genetic modification of a strain of Rut-C30 fungus, comprising a step of invalidating the ceUa gene.
- This step of invalidation of the ceUa gene is carried out in particular by mutagenesis, by homologous recombination or more preferably using an invalidation cassette represented by SEQ ID NO: 3.
- Mutagenesis is a technique commonly used in genetic engineering. It aims to intentionally introduce mutations into DNA in order to create genetically modified genes. According to the invention, mutagenesis is more particularly understood as site-directed mutagenesis. Site-directed mutagenesis makes it possible to introduce identified mutations into a specific gene. To do this, the DNA of interest (here the ceUa gene) containing the mutations is synthesized and then introduced into the cell to be mutated, typically using a vector, where the DNA repair mechanism takes place. takes care of integrating it into the genome.
- Homologous recombination is a technique commonly used in genetic engineering which consists of an exchange between DNA molecules, typically using a vector.
- vector is understood to mean any DNA sequence into which it is possible to insert fragments of foreign nucleic acid, the vectors allowing the introduction of foreign DNA into a host cell.
- vectors are plasmids, cosmids, artificial yeast chromosomes (Y AC), artificial bacterial chromosomes (BAC) and artificial chromosomes derived from bacteriophage P1 (PAC), vectors derived from viruses.
- the vector according to the invention allows the introduction of a mutation or a deletion.
- said invalidation cassette comprises three DNA fragments:
- the "target gene” is understood to mean the ceUa gene.
- the regions upstream and downstream of the target gene are two recombinant elements, one at each end of the gene, and are necessary to precisely target the sequence to be invalidated.
- the region upstream of the target gene (that is to say the sequence 5 ′ upstream of the ceUa gene) is in particular represented by the sequence of SEQ ID NO: 4.
- the region downstream of the target gene (that is to say the sequence 3 'downstream of the ce! 1a gene is in particular represented by the sequence of SEQ ID NO: 5.
- selection marker means a gene whose expression confers on the cells which contain it a characteristic allowing them to be selected.
- the use of a selection marker in fact makes it possible to identify the cells which have integrated a genetic modification compared to those which have not integrated it. It is for example a gene for resistance to antibiotics, in particular the gene for resistance to the antibiotic hygromycin hph, as represented by the sequence of SEQ ID NO: 6.
- the invalidation cassette preferably consists of a resistance gene placed under the control of a promoter and of a terminator, with the 5 ′ flanking regions upstream and downstream. and 3 'of the cella gene.
- said invalidation cassette may be operably linked to a promoter, a terminator or any other sequence necessary for its expression in a host cell.
- the invalidation cassette can be amplified according to conventional techniques well known to those skilled in the art, typically by a method chosen from conventional cloning, PCR fusion, or else in vivo cloning by PCR.
- this invalidation cassette is amplified by PCR, in particular using the sequences represented by SEQ ID NO: 9 and SEQ ID NO: 11.
- the invalidation cassette is then introduced by recombination into a strain of Trichoderma, in particular Trichoderma reesei, which does not express a gene for the selection marker.
- the variant / mutant strains having incorporated the invalidation cassette are selected according to the expression or not of the selection marker; the clones which have been transformed expressing said selection marker.
- the mutant strains are identified using the primers of SEQ ID NO: 8 and SEQ ID NO: 13.
- FIG. 1 represents the plasmid pRS426-Acel1a-hph which was used to obtain a strain in which the cella gene has been invalidated.
- the positions of the various fragments of the invalidation cassette and of the oligonucleotides used for the construction are indicated.
- FIG. 2 shows the optimization of the composition of the lactose / glucose mixture used as a feed solution for the protein production phase by Trichoderma reesei RutC30-Acel1a.
- FIG. 3 shows the comparison of the specific bioreactor productivity of the RutC30 and RutC30-4ce / 7a strains when they are fed in fed-batch mode with sugar solutions of different compositions.
- Example 1 Invalidation of the cella gene in a hvperproductive strain
- the flanking regions (1 kb) of cella were amplified from genomic DNA of T. reesei using Phusion polymerase (Thermo Fisher Scientific) and using the following oligonucleotides: cel1a-5F and cel1a-5R; cel1a-3F and cel1a-3R (see Table 2).
- the hph marker was amplified from the plasmid pLHhphl using the hphF and hphR oligonucleotides (Hartl et al., 2007).
- the oligonucleotides used for the amplification of the flanking regions overlap the different fragments of the construction ( Figure 1).
- the deletion cassette will be assembled in the plasmid pRS426 by homologous recombination during passage into yeast. Transformation of the yeasts was carried out using the method described by Schiestl and Gietz (1989).
- the yeast strain ATCC 208405 was transformed with the two flanking regions, the hph marker and the pla smide pRS426 digested beforehand with EcoRI and Xbal (Christianson et al., 1992) to give the plasmid pRS426 -Acel1a-hph.
- the plasmid was then introduced and amplified in the thermocompetent NEB 10-beta E.
- the oligonucleotides cel1a-3F and cell-5R were used to amplify the invalidation cassette from the plasmid pRS42Q-Acel1a-hph.
- the cassette was purified using the QIAquick PCR purification kit (QIAGEN).
- the strain used for transformation is the hyperproductive strain RutC30 (Montenecourt and Eveleigh, 1977).
- the strain was transformed by the protoplast method (Penttila et al. (1987) using 1 ⁇ g of purified cassette.
- the integration of the hph cassette was verified by PCR using the oligonucleotides cel1a_ch and hphR so as to obtain a PCR produced only if the cassette was correctly inserted.
- Three independent clones were isolated and analyzed as biological replicates. The sequences and names of the primers are shown in Tables 1 and 2.
- the strain invalidated for the cella gene is named RutC30- Acel1a.
- the cultures in supplied flasks are carried out in Erlenmeyer flasks 8 cm in diameter, containing 60 ml of culture medium, inoculated with spores of the desired strain stored in cryotubes, and incubated at 150 rpm and 30 ° C. in an Infors Multitron incubator.
- the culture medium has the following final composition:
- the first growth phase is carried out for 48 hours until the glucose is used up, which causes the medium to acidify to a pH of about 3.5.
- the pH is then raised to approximately 4.3 by adding sodium hydroxide.
- the second production phase is carried out for 48 hours by feeding at 0.3 mL / h of a "fed-batch" solution containing:
- the RutC30-Acel1a strain was cultured according to the protocol described in Example 2 in order to measure the specific protein productivity of the strain when it is fed in fed-batch with different glucose / lactose mixtures.
- the glucose / lactose mixtures tested ranged from 99% glucose / 1% lactose to 50% glucose / 50% lactose.
- The% here refers to the total amount of sugars present in the solution.
- the cultures in bioreactors are carried out in fermenters 10 cm in diameter, containing 800 ml of culture medium, inoculated at 10% v / v from a preculture.
- Stirring is carried out by a Rushton turbine and a 5 cm diameter pitch-blade turbine.
- the stirring speed is controlled between 400 and 1200 rpm to maintain a dissolved oxygen concentration greater than 40% of the saturation concentration.
- the temperature is controlled at 27 ° C during the 1 st stage and then at 25 ° C for the 2nd phase.
- the pH is controlled throughout the culture at 4.0 by automatic addition of a 5N ammonia solution.
- the preculture is carried out in flasks 19 cm in diameter containing 250 mL of the same culture medium, buffered with 5 g / L of dipotassium phthalate and the initial pH of which is adjusted to 5.0 with sodium hydroxide.
- the precultures are inoculated with spores of the desired strain stored in cryotubes, and incubated at 150 rpm and 30 ° C. in an Infors Multitron incubator.
- the culture medium has the following final composition:
- the first phase (batch growth on glucose) is carried out for 27 to 30 h (until glucose is used up), then the 2 nd phase (production of proteins in fed-batch mode) is carried out for 70 h by feeding 'a 250g / L sugar solution containing either pure lactose or a mixture of lactose and glucose.
- Example 5 Comparison of the performances of the RutC30 and RutC30-Acella strains using solutions of purified sugars as substrate.
- the wild strain RutC30 fed with a solution of pure lactose has a specific productivity of 20 to 22 mg P rotein / g biomass / h. Feed the same strain with a solution containing a mixture consisting of 10% lactose and 90% glucose gives a specific productivity approximately 2.5 times lower, around 8 mg pr otéines / gbiomasse / h. This strategy would therefore have no industrial interest because the additional cost linked to lower productivity would not be offset by the savings made by using less lactose.
- the strain RutC30-Acel1a fed with a pure lactose solution has a very low specific productivity around 3 mg pra teins / gbiomasse / h, since it is no longer able to absorb large amounts of lactose.
- the RutC30-Acel1a strain has a specific productivity of between 16 and 19 mg P rotein / gbiomass / h, almost as good as the RutC30 strain fed with pure lactose. With 10% or 15% lactose in the mixture, a specific productivity equivalent (not significantly different) to the RutC30 control fed with pure lactose was observed.
- Example 6 Performance of the RutC30-4cel1a strain by incorporating industrial solutions as production substrate
- cultures in a bioreactor were carried out by incorporating a crude extract of water-soluble pentoses originating from the pretreatment of a lignocellulosic biomass. This extract is incorporated as a replacement for water for the preparation of feed solutions for the fed-batch production phase.
- the cultures are carried out according to the protocol described in Example 4, with the only difference that the feed solution for the 2 nd phase (production phase) was prepared by dissolving the glucose and the lactose in the. crude extract of hydrosoluble pentoses, so as to obtain a solution containing a total of 500g S ucres / L S oiution and a lactose content of 0%, 5%, or 10% (% of total sugars) as appropriate.
- the results are shown in Table 3 below.
- the RutC30-Acel1a strain fed with a solution containing a crude extract of water-soluble pentoses (obtained from both wheat straw and corn straw) maintains a specific speed of maximum protein production (around 21 to 22 mg pra teins / gbiomasse / h) even if the lactose content of the solution is only 10% or 5%.
- Table 3 shows the specific bioreactor productivity of the RutC30 -ûceUa strain when it is fed in fed-batch mode with solutions of sugars of different compositions and prepared using a crude extract of water-soluble pentoses obtained from corn straw or wheat straw.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA3182330A CA3182330A1 (fr) | 2020-06-22 | 2021-06-21 | Procede de production de proteines par une souche de champignon trichoderma dans laquelle le gene cel1 a est invalide |
CN202180051516.7A CN116323909A (zh) | 2020-06-22 | 2021-06-21 | 使用已敲除cel1a基因的木霉属真菌菌株生产蛋白质的方法 |
US18/011,604 US20230303991A1 (en) | 2020-06-22 | 2021-06-21 | Method of Producing Proteins Using a Trichoderma Fungus Strain in Which the CEL1A Gene is Invalidated |
BR112022026007A BR112022026007A2 (pt) | 2020-06-22 | 2021-06-21 | Método para produzir proteínas usando uma cepa do fungo trichoderma na qual o gene cel1a foi nocauteado |
EP21740145.4A EP4168531A1 (fr) | 2020-06-22 | 2021-06-21 | Procédé de production de proteines par une souche de champignon trichoderma dans laquelle le gène cel1 a est invalidé |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR2006495 | 2020-06-22 | ||
FR2006495A FR3111643A1 (fr) | 2020-06-22 | 2020-06-22 | Procede de production de proteines, de sucres, d’alcool, par une souche de champignon trichoderma dans laquelle le gene cel1a est invalide |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2021260310A1 true WO2021260310A1 (fr) | 2021-12-30 |
Family
ID=73698904
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR2021/051117 WO2021260310A1 (fr) | 2020-06-22 | 2021-06-21 | Procédé de production de proteines par une souche de champignon trichoderma dans laquelle le gène cel1 a est invalidé |
Country Status (7)
Country | Link |
---|---|
US (1) | US20230303991A1 (fr) |
EP (1) | EP4168531A1 (fr) |
CN (1) | CN116323909A (fr) |
BR (1) | BR112022026007A2 (fr) |
CA (1) | CA3182330A1 (fr) |
FR (1) | FR3111643A1 (fr) |
WO (1) | WO2021260310A1 (fr) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0448430B1 (fr) | 1990-03-19 | 1996-01-10 | Institut Français du Pétrole | Composition d'enzymes adaptée à l'hydrolyse des polysaccharides d'un substrat lignocellulosique, sa préparation et son utilisation |
EP1690944A1 (fr) * | 2005-02-09 | 2006-08-16 | Institut Français du Pétrole | Procédé de production d'enzymes cellulolytiques et hémicellulolytiques utilisant les résidus de distillation de fermentation éthanolique d'hydrolysats enzymatiques de materiaux (ligno-)cellulosiques |
JP2014150745A (ja) * | 2013-02-06 | 2014-08-25 | Nagaoka Univ Of Technology | トリコデルマ属に属する微生物の変異株および該変異株の使用 |
EP2744899B1 (fr) | 2011-08-19 | 2016-02-24 | IFP Energies nouvelles | Procédé de production de cellulases par un champignon filamenteux adapté à un fermenteur ayant un faible coefficient de transfert volumetrique d'oxygène kla |
WO2019120994A1 (fr) | 2017-12-20 | 2019-06-27 | IFP Energies Nouvelles | Procede de traitement de biomasse ligno-cellulosique par impregnation |
EP3587583A1 (fr) | 2018-06-27 | 2020-01-01 | IFP Energies nouvelles | Procede de traitement de biomasse ligno-cellulosique |
-
2020
- 2020-06-22 FR FR2006495A patent/FR3111643A1/fr active Pending
-
2021
- 2021-06-21 EP EP21740145.4A patent/EP4168531A1/fr active Pending
- 2021-06-21 BR BR112022026007A patent/BR112022026007A2/pt unknown
- 2021-06-21 CN CN202180051516.7A patent/CN116323909A/zh active Pending
- 2021-06-21 US US18/011,604 patent/US20230303991A1/en active Pending
- 2021-06-21 CA CA3182330A patent/CA3182330A1/fr active Pending
- 2021-06-21 WO PCT/FR2021/051117 patent/WO2021260310A1/fr active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0448430B1 (fr) | 1990-03-19 | 1996-01-10 | Institut Français du Pétrole | Composition d'enzymes adaptée à l'hydrolyse des polysaccharides d'un substrat lignocellulosique, sa préparation et son utilisation |
EP1690944A1 (fr) * | 2005-02-09 | 2006-08-16 | Institut Français du Pétrole | Procédé de production d'enzymes cellulolytiques et hémicellulolytiques utilisant les résidus de distillation de fermentation éthanolique d'hydrolysats enzymatiques de materiaux (ligno-)cellulosiques |
EP2744899B1 (fr) | 2011-08-19 | 2016-02-24 | IFP Energies nouvelles | Procédé de production de cellulases par un champignon filamenteux adapté à un fermenteur ayant un faible coefficient de transfert volumetrique d'oxygène kla |
JP2014150745A (ja) * | 2013-02-06 | 2014-08-25 | Nagaoka Univ Of Technology | トリコデルマ属に属する微生物の変異株および該変異株の使用 |
WO2019120994A1 (fr) | 2017-12-20 | 2019-06-27 | IFP Energies Nouvelles | Procede de traitement de biomasse ligno-cellulosique par impregnation |
EP3587583A1 (fr) | 2018-06-27 | 2020-01-01 | IFP Energies nouvelles | Procede de traitement de biomasse ligno-cellulosique |
Non-Patent Citations (14)
Title |
---|
CHRISTIANSON, T. W.SIKORSKI, R. S.DANTE, M.SHERO, J. H.HIETER, P.: "Multifunctional yeast high-copy-number shuttle vectors", GENE, vol. 110, no. 1, 1992, pages 119 - 122, XP023542303, DOI: 10.1016/0378-1119(92)90454-W |
GUO BOYANG ET AL: "Improvements in Glucose Sensitivity and Stability of Trichoderma reesei [beta]-Glucosidase Using Site-Directed Mutagenesis", vol. 11, no. 1, 20 January 2016 (2016-01-20), pages e0147301, XP055778542, Retrieved from the Internet <URL:https://storage.***apis.com/plos-corpus-prod/10.1371/journal.pone.0147301/1/pone.0147301.pdf?X-Goog-Algorithm=GOOG4-RSA-SHA256&[email protected]/20210222/auto/storage/goog4_request&X-Goog-Date=20210222T160443Z&X-Goog-Expires=3600&X-Goog-SignedHeaders=ho> DOI: 10.1371/journal.pone.0147301 * |
HARTL, LUKASKUBICEK, CHRISTIAN P.SEIBOTH, BERNHARD: "Induction of the gai pathway and cellulase genes involves no transcriptional inducer function of the galactokinase in Hypocrea jecorina", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 282, no. 25, 2007, pages 18654 - 18659, XP055229060, DOI: 10.1074/jbc.M700955200 |
JOURDIER ET AL., BIOTECHNOLOGY FOR BIOFUELS, vol. 6, 2013, pages 79 |
M. SALOHEIMOJ. KUJA-PANULAE. YLÔSMÀKI ET AL.: "Enzymatic Properties and Intracellular Localization of the Novel Trichoderma reesei {3-Glucosidase BGLII (CellA)", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, vol. 68, no. 9, 2002, pages 4546 - 4553, XP002967101, DOI: 10.1128/AEM.68.9.4546-4553.2002 |
MARKOV, A.V.GUSAKOV, A.V.KONDRATYEVA, E.G.OKUNEV, O.N.BEKKAREVICH, A.O.SINITSYN, A.P.: "New Effective Method for Analysis of the Component Composition of Enzyme Complexes from Trichoderma reesei", BIOCHEMISTRY, vol. 70, 2005, pages 657 - 663, XP008068738, DOI: 10.1007/s10541-005-0166-4 |
MONTENECOURT, B. S.EVELEIGH, D. E.: "Semiquantitative Plate Assay for Détermination of Cellulase Production by Trichoderma viride", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, vol. 33, no. 1, 1977, pages 178 - 183 |
R. PETERSON ET AL: "Trichoderma reesei RUT-C30 - thirty years of strain improvement", MICROBIOLOGY, vol. 158, no. 1, 13 October 2011 (2011-10-13), pages 58 - 68, XP055105400, ISSN: 1350-0872, DOI: 10.1099/mic.0.054031-0 * |
SCHIESTL, ROBERT H.GIETZ, R. DANIEL: "High efficiency transformation of intact yeast ceiis using single stranded nucleic acids as a carrier", CURRENT GENETICS, vol. 16, no. 5, 1989, pages 339 - 346 |
SHIDA YOSUKE ET AL: "The impact of a single-nucleotide mutation of bgl2 on cellulase induction in a Trichoderma reesei mutant", vol. 8, no. 1, 1 December 2015 (2015-12-01), pages 1 - 18, XP055778563, Retrieved from the Internet <URL:https://biotechnologyforbiofuels.biomedcentral.com/track/pdf/10.1186/s13068-015-0420-y.pdf> DOI: 10.1186/s13068-015-0420-y * |
XU ET AL.: "Intracellular /3-Glucosidases CEL 1 a and CEL 1 b Are Essential for Cellulase Induction on Lactose in Trichoderma reesei", EUKARYOTIC CELL, vol. 13, no. 8, 2014, pages 1001 - 1013 |
XU JINTAO ET AL: "Intracellular Beta-Glucosidases CEL1a and CEL1b Are Essential for Cellulase Induction on Lactose in Trichoderma reesei", vol. 13, no. 8, 30 May 2014 (2014-05-30), US, pages 1001 - 1013, XP055778544, ISSN: 1535-9778, Retrieved from the Internet <URL:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4135799/pdf/zek1001.pdf> DOI: 10.1128/EC.00100-14 * |
ZHOU ET AL.: "Differentiai involvement of {3-Glucosidases from Hypocrea jecorina in Rapid Induction of Cellulase Genes by Cellulose and Cellobiose", EUKARYOTIC CELL, vol. 11, no. 11, 2012, pages 1371 - 1381, XP055778557, DOI: 10.1128/EC.00170-12 |
ZHOU QINGXIN ET AL: "Differential Involvement of beta-Glucosidases from Hypocrea jecorina in Rapid Induction of Cellulase Genes by Cellulose and Cellobiose", EUKARYOTIC CELL, vol. 11, no. 11, November 2012 (2012-11-01), pages 1371 - 1381, XP055778557 * |
Also Published As
Publication number | Publication date |
---|---|
CN116323909A (zh) | 2023-06-23 |
CA3182330A1 (fr) | 2021-12-30 |
US20230303991A1 (en) | 2023-09-28 |
BR112022026007A2 (pt) | 2023-03-14 |
FR3111643A1 (fr) | 2021-12-24 |
EP4168531A1 (fr) | 2023-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2342329B1 (fr) | Variants de beta-glucosidase a activite amelioree et leurs utilisations | |
EP3158071B1 (fr) | Variants d'exoglucanases a activite amelioree et leurs utilisations | |
EP2593543B1 (fr) | Procédé de production d'enzymes cellulolytiques et/ou hémicellulolytiques amélioré | |
EP3158076B1 (fr) | Variants d'exoglucanases a activite amelioree et leurs utilisations | |
WO2021111090A1 (fr) | Souche de champignon ayant une viscosite diminuee | |
EP4168531A1 (fr) | Procédé de production de proteines par une souche de champignon trichoderma dans laquelle le gène cel1 a est invalidé | |
CA2883715C (fr) | Polypeptide a activite beta-glucosidase renforcee a basse temperature | |
EP3071692B1 (fr) | Variants d'endoglucanases a activite amelioree et leurs utilisations | |
EP3071693B1 (fr) | Variants d'endoglucanases a activite amelioree et leurs utilisations | |
FR3128470A1 (fr) | Souche de champignon hyperproductrice de proteines | |
CA3215584A1 (fr) | Insertion multicopies d'un gene d'interet dans le genome d'un champignon | |
WO2023186568A1 (fr) | Procédé de production d'enzymes cellulolytiques et/ou hémicellulytiques | |
FR3113291A1 (fr) | Procédé de production d’alcool par hydrolyse enzymatique et fermentation de biomasse lignocellulosique |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21740145 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 3182330 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 202217072633 Country of ref document: IN |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112022026007 Country of ref document: BR |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2021740145 Country of ref document: EP Effective date: 20230123 |
|
ENP | Entry into the national phase |
Ref document number: 112022026007 Country of ref document: BR Kind code of ref document: A2 Effective date: 20221219 |